Konakion Novum

Phytomenadione, the active ingredient in Konakion Novum, is a vitamin K presented as an injectable solution for intramuscular, intravenous, or oral use. It treats vitamin K deficiency, helps prevent hemorrhage in newborns, and reverses anticoagulation caused by warfarin or other vitamin K antagonists.

GNH USA supplies Konakion Novum as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, transplant centres and clinics worldwide with reliable logistics and quality assurance. Our network ensures timely delivery and compliance with local regulatory requirements.

Konakion Novum (phytomenadione) is used to correct disorders of the vitamin K‑dependent clotting cascade.

- Vitamin K deficiency: restores normal clotting factor activity and reduces bleeding risk. - Newborn hemorrhage prevention: provides essential vitamin K to newborns to lower incidence of early‑life bleeding. - Warfarin reversal: rapidly re‑establishes coagulation in patients over‑anticoagulated with vitamin K antagonists.

Phytomenadione may cause adverse reactions, ranging from mild to severe.

Common Side Effects: - Injection site pain: discomfort at the site of intramuscular or intravenous administration. - Erythema: localized redness around the injection area. - Mild fever: transient elevation of body temperature. - Nausea: occasional feeling of queasiness after dosing.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe hypersensitivity: including rash, swelling, or respiratory distress. - Thrombosis: formation of abnormal blood clots. - Hemolysis: destruction of red blood cells. - Elevated liver enzymes: indicating hepatic stress. - Disseminated intravascular coagulation: widespread clotting abnormalities.

Before using Konakion Novum, consider the following safety measures.

- Assess vitamin K status before use: evaluate baseline coagulation parameters. - Monitor coagulation parameters after administration: check INR or PT as appropriate. - Use with caution in patients with liver disease: hepatic impairment may affect metabolism. - Avoid in individuals with known hypersensitivity to phytonadione: discontinue if allergic signs appear. - Pregnancy and lactation: administer only if the expected benefit justifies the potential risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Konakion Novum can interact with several medicines; awareness helps prevent reduced efficacy or increased risk.

Major Interactions (Avoid): - Warfarin: antagonizes anticoagulant effect, reducing therapeutic benefit. - Broad‑spectrum antibiotics (e.g., cephalosporins): may alter gut flora and affect vitamin K levels. - Other vitamin K antagonists (e.g., acenocoumarol): reduced efficacy when co‑administered.

Moderate Interactions (Monitor Closely): - Cefoperazone and cefamandole: may increase bleeding risk when combined. - Barbiturates: may increase vitamin K metabolism, potentially requiring dose adjustment. - Oral contraceptives: may affect clotting parameters and warrant monitoring.